Katrina Pass

Uro- Oncology Business Manager- Immunity Bio

Role: Uro-oncology Business Manager at ImmunityBio, Inc.
Location: Orlando, FL, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Katrina Pass

I am an Alumni of The University of Tennessee, and currently a Uro Oncology Business…

Experience

Uro-oncology Business Manager
ImmunityBio, Inc.
Jan 2025 — Present · FL, US
ANKTIVA is an interleukin-15 (IL-15) receptor agonist indicated with Bacillus Calmette-Guérin (BCG) for the treatment of adult patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.

Education

University of Tennessee, Knoxville
Communication Studies
2013 — 2017

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@immunitybio.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

ImmunityBio, Inc.

Biotechnology Research · 661 employees · Founded 2014 · San Diego, California, United States

ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells. The activation of the innate immune system is key to the development of immunological memory. Over the last two decades, our founder and Executive Chairman Dr. Patrick Soon-Shiong has investigated mechanisms to activate the immune system to attack tumors that can otherwise evade and escape the body’s defense mechanisms. After inventing the world’s first protein nanoparticle drug, Abraxane, Dr. Soon-Shiong turned his focus to the next generation of immunotherapies. ImmunityBio was founded in 2014 to create innovative immunotherapies that address serious unmet needs in oncology and infectious diseases. "At ImmunityBio, we envision a day when we no longer fear cancer but are able to conquer it, thanks to the biological wonder that is the human immune system. Our scientists are working to develop remarkable new therapies that harness that inherent power by amplifying both branches of the immune system, attacking cancerous or infected cells today while building immunological memory for tomorrow. The goal: to reprogram the patient’s immune system and treat the host rather than just the disease." -Dr. Patrick Soon-Shiong, Executive Chairman

immunitybio.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Katrina Pass

Experience

Uro-oncology Business Manager

Education

University of Tennessee, Knoxville

Find verified contacts for anyone on LinkedIn